GLAXOSMITHKLINE PLC

INVA

GLAXOSMITHKLINE PLC serves as 10% Owner at Innoviva, Inc. (INVA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$4.95M

Total Sells

1 trades

$392.06M

Net Position

Net Seller

$387.11M

Companies Traded

CVRX, INVA

Active Period

May 2021 – Jul 2021

2 total trades

Most Recent

Buy CVRX

Jul 2, 2021 · $4.95M

GLAXOSMITHKLINE PLC's Insider Trading at Innoviva, Inc. (INVA)

Buys

0 · $0.00

Sells

1 · $392.06M

Total Shares Bought

Total Shares Sold

32,005,260

INVA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 24, 2021↗	Sell	32,005,260	$12.25	$392.06M	0

GLAXOSMITHKLINE PLC's Insider Trading at CVRx, Inc. (CVRX)

Buys

1 · $4.95M

Sells

0 · $0.00

Total Shares Bought

275,000

Total Shares Sold

CVRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jul 2, 2021↗	Buy	275,000	$18.00	$4.95M	0

Related Insiders

Kevin Hykes

director, officer: PRES & CEO

CVRXSell · Mar 2, 2026

Robert Allen John

officer: Chief Revenue Officer

CVRXSell · Mar 2, 2026

VERRASTRO PAUL

officer: CHIEF MKTG & STRAT OFFICER

CVRXSell · Mar 2, 2026

OASHEIM JARED

officer: CHIEF FINANCIAL OFFICER

CVRXSell · Mar 2, 2026

Mudit K. Jain

director

CVRXBuy · Feb 20, 2026

Mudit K. Jain

Director

CVRXBuy · Feb 20, 2026

JOHNSON & JOHNSON

10 percent owner

CVRXSell · Nov 26, 2025

Marianne Zhen

Chief Accounting Officer

INVASell · Nov 20, 2025

Explore More Insider Trading Data

INVA Insider Trading Activity

View all insider trades at Innoviva, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity